La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.

Identifieur interne : 002F68 ( Main/Exploration ); précédent : 002F67; suivant : 002F69

PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.

Auteurs : Michael H. Gollob [Canada] ; Martin S. Green ; Anthony S L. Tang ; Robert Roberts

Source :

RBID : pubmed:12015471

English descriptors

Abstract

Genetic studies of families with inherited cardiac rhythm disturbances have established a molecular basis for ventricular arrhythmogenic disorders. Genes responsible for the long QT syndrome, Brugada syndrome, and polymorphic ventricular tachycardia have been identified. The elucidation of genetic defects responsible for more commonly occurring supraventricular rhythm disturbances have not been as forthcoming, with the exception of SCN5A mutations known to cause conduction system disease. Recently, we identified the genetic cause of a familial arrhythmogenic syndrome characterized by ventricular preexcitation and tachyarrhythmias (Wolff-Parkinson-White syndrome), progressive conduction system disease, and cardiac hypertrophy. The causative gene was shown to be the gamma-2 regulatory subunit (PRKAG2) of AMP-activated protein kinase. The role of AMP-activated protein kinase in the regulation of the glucose metabolic pathway in muscle suggests that genetic defects in PRKAG2 may induce a previously undescribed cardiac glycogenosis syndrome.

PubMed: 12015471


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.</title>
<author>
<name sortKey="Gollob, Michael H" sort="Gollob, Michael H" uniqKey="Gollob M" first="Michael H" last="Gollob">Michael H. Gollob</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Cardiology, University of Western Ontario, London Health Sciences Center, Ontario, Canada. mgollob@uwo.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Cardiology, University of Western Ontario, London Health Sciences Center, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Green, Martin S" sort="Green, Martin S" uniqKey="Green M" first="Martin S" last="Green">Martin S. Green</name>
</author>
<author>
<name sortKey="Tang, Anthony S L" sort="Tang, Anthony S L" uniqKey="Tang A" first="Anthony S L" last="Tang">Anthony S L. Tang</name>
</author>
<author>
<name sortKey="Roberts, Robert" sort="Roberts, Robert" uniqKey="Roberts R" first="Robert" last="Roberts">Robert Roberts</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12015471</idno>
<idno type="pmid">12015471</idno>
<idno type="wicri:Area/PubMed/Corpus">001514</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001514</idno>
<idno type="wicri:Area/PubMed/Curation">001514</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001514</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001514</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001514</idno>
<idno type="wicri:Area/Ncbi/Merge">000225</idno>
<idno type="wicri:Area/Ncbi/Curation">000225</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000225</idno>
<idno type="wicri:doubleKey">0268-4705:2002:Gollob M:prkag:cardiac:syndrome</idno>
<idno type="wicri:Area/Main/Merge">003386</idno>
<idno type="wicri:Area/Main/Curation">002F68</idno>
<idno type="wicri:Area/Main/Exploration">002F68</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.</title>
<author>
<name sortKey="Gollob, Michael H" sort="Gollob, Michael H" uniqKey="Gollob M" first="Michael H" last="Gollob">Michael H. Gollob</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Cardiology, University of Western Ontario, London Health Sciences Center, Ontario, Canada. mgollob@uwo.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Cardiology, University of Western Ontario, London Health Sciences Center, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Green, Martin S" sort="Green, Martin S" uniqKey="Green M" first="Martin S" last="Green">Martin S. Green</name>
</author>
<author>
<name sortKey="Tang, Anthony S L" sort="Tang, Anthony S L" uniqKey="Tang A" first="Anthony S L" last="Tang">Anthony S L. Tang</name>
</author>
<author>
<name sortKey="Roberts, Robert" sort="Roberts, Robert" uniqKey="Roberts R" first="Robert" last="Roberts">Robert Roberts</name>
</author>
</analytic>
<series>
<title level="j">Current opinion in cardiology</title>
<idno type="ISSN">0268-4705</idno>
<imprint>
<date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AMP-Activated Protein Kinases</term>
<term>Adult</term>
<term>Cardiomegaly (complications)</term>
<term>Cardiomegaly (genetics)</term>
<term>Gene Expression Regulation, Enzymologic (genetics)</term>
<term>Genetic Predisposition to Disease</term>
<term>Heart Conduction System (physiopathology)</term>
<term>Humans</term>
<term>Male</term>
<term>Multienzyme Complexes (genetics)</term>
<term>Pre-Excitation Syndromes (complications)</term>
<term>Pre-Excitation Syndromes (genetics)</term>
<term>Protein-Serine-Threonine Kinases (genetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Multienzyme Complexes</term>
<term>Protein-Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>AMP-Activated Protein Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Cardiomegaly</term>
<term>Pre-Excitation Syndromes</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Cardiomegaly</term>
<term>Gene Expression Regulation, Enzymologic</term>
<term>Pre-Excitation Syndromes</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Heart Conduction System</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Genetic studies of families with inherited cardiac rhythm disturbances have established a molecular basis for ventricular arrhythmogenic disorders. Genes responsible for the long QT syndrome, Brugada syndrome, and polymorphic ventricular tachycardia have been identified. The elucidation of genetic defects responsible for more commonly occurring supraventricular rhythm disturbances have not been as forthcoming, with the exception of SCN5A mutations known to cause conduction system disease. Recently, we identified the genetic cause of a familial arrhythmogenic syndrome characterized by ventricular preexcitation and tachyarrhythmias (Wolff-Parkinson-White syndrome), progressive conduction system disease, and cardiac hypertrophy. The causative gene was shown to be the gamma-2 regulatory subunit (PRKAG2) of AMP-activated protein kinase. The role of AMP-activated protein kinase in the regulation of the glucose metabolic pathway in muscle suggests that genetic defects in PRKAG2 may induce a previously undescribed cardiac glycogenosis syndrome.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Green, Martin S" sort="Green, Martin S" uniqKey="Green M" first="Martin S" last="Green">Martin S. Green</name>
<name sortKey="Roberts, Robert" sort="Roberts, Robert" uniqKey="Roberts R" first="Robert" last="Roberts">Robert Roberts</name>
<name sortKey="Tang, Anthony S L" sort="Tang, Anthony S L" uniqKey="Tang A" first="Anthony S L" last="Tang">Anthony S L. Tang</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Gollob, Michael H" sort="Gollob, Michael H" uniqKey="Gollob M" first="Michael H" last="Gollob">Michael H. Gollob</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F68 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F68 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:12015471
   |texte=   PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:12015471" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022